VNET Group Inc vs Health Care Select Sector SPDR Fund — how do they compare? VNET Group Inc trades at $5.26 (market cap $1.47B), while Health Care Select Sector SPDR Fund trades at $168.48 (market cap $43.48B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 29.6× VNET Group Inc's market cap, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, VNET Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold VNET Group Inc for 16 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| VNET | XLV | |
|---|---|---|
Market Cap | $1.47B | $43.48B |
Volume | 4,955,295 | 11,121,431 |
Sector | Technology | — |
52-Week High | $14.03 | $175.68 |
52-Week Low | $5.13 | $141.95 |
Typical Hold Time | 16 Days | 100 Days |
Enterprise Value | $5.04B | — |
Signals from Pluang's Aura AI — not financial advice
VNET trades at $5.39, near a 52-week low, with a bearish technical signal and negative earnings misses in recent quarters. The company reported a net loss of $256.77 million in 2025, with a negative net income margin of -22.18%, though revenue grew to $9.95 billion. Positive cash flow from operations of $1.92 billion and a strategic investment closing in September 2026 provide some operational stability amid financial challenges.
The outlook remains cautious due to persistent losses and high leverage, but analyst consensus is moderately bullish with 62.5% buy ratings. Key risks include balance sheet pressures and competitive threats in the data center market, while potential upside hinges on execution of new capacity and AI infrastructure demand.
XLV trades at $168.81, up 1.03% today, with a bullish technical signal driven by moving averages. The ETF holds 61 healthcare stocks from the S&P 500, offering broad sector exposure at a low 0.08% expense ratio. Recent news highlights its defensive appeal amid market volatility and potential Fed rate hikes, with articles comparing it favorably to peers like IBB and PJP on cost and diversification.
Outlook is positive given healthcare's defensive growth profile and XLV's cost efficiency, but risks include political uncertainty from midterm elections and sector-specific volatility from drug trial outcomes. Wall Street sentiment is constructive, with the ETF near key resistance at $170.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
VNET Group, formerly 21Vianet, is a leading carrier-neutral data center services provider in China. It operates a dual-core strategy: a large-scale retail business serving over 7,000 enterprise customers and an aggressive wholesale segment (Hyperscale 2.0) designed to meet the high-density power and cooling demands of large-scale AI and cloud platforms.
Read more on VNET →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →